Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare
Urogen Pharma Ltd. Net Income 2016–2025
Urogen Pharma Ltd. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Urogen Pharma Ltd. net income for the quarter ending March 31, 2026 was -23.6 M, a 46.23% decrease year-over-year.
- Urogen Pharma Ltd. net income for the twelve months ending March 31, 2026 was -150.7 M, a 35.48% increase year-over-year.
- Urogen Pharma Ltd. annual net income for 2025 was -153.5 M, a 20.98% increase from 2024.
- Urogen Pharma Ltd. annual net income for 2024 was -126.9 M, a 24.09% increase from 2023.
- Urogen Pharma Ltd. annual net income for 2023 was -102.2 M, a 6.87% decrease from 2022.
- Urogen Pharma Ltd. annual net income for 2022 was -109.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Urogen Pharma Ltd. Net Income — FAQ
Urogen Pharma Ltd. (URGN) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Urogen Pharma Ltd.'s net income?
Urogen Pharma Ltd. (URGN) reported net income of -$153M for fiscal 2025.
Where can I see URGN's net income history?
The chart and table above show Urogen Pharma Ltd.'s net income by year and by quarter, including the growth rate.